REQUEST A DEMO
Total
USD $0.00
Search more companies

Sarrazola Alergia E Inmunologia Ips S.A.S. (Colombia)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Pharmacies and Drug Stores | Other Schools and Instruction
Full name: Sarrazola Alergia E Inmunologia Ips S.A.S. Profile Updated: January 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Sarrazola Alergia E Inmunologia Ips S.A.S. is an enterprise located in Colombia, with the main office in Cucuta. It operates in the Ambulatory Health Care Services sector. It was first established on May 03, 2022. In 2025, the company reported a net sales revenue increase of 83.32%. Its total assets grew by 207.42% over the same period. In 2025, Sarrazola Alergia E Inmunologia Ips S.A.S.’s net profit margin increased by 14.92%.

Headquarters
Cl 13 1 E 44 Cs 508 B Brr Caobos
Cucuta; Norte de Santander;

Contact Details: Purchase the Sarrazola Alergia E Inmunologia Ips S.A.S. report to view the information.

Basic Information
Registered Capital:
Purchase the Sarrazola Alergia E Inmunologia Ips S.A.S. report to view the information.
Financial Auditors:
Purchase the Sarrazola Alergia E Inmunologia Ips S.A.S. report to view the information.
Incorporation Date:
May 03, 2022
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Sarrazola Alergia E Inmunologia Ips S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
83.32%
Total Operating Revenue
83.32%
Operating Profit
165.07%
EBITDA
155.39%
Net Profit/Loss for the Period
157.8%
Total Assets
207.42%
Total Equity
206.47%
Operating Profit Margin
16.92%
Net Profit Margin
14.92%
Return on Equity (ROE)
-12.89%
Quick Ratio
0.35%
Cash Ratio
-0.53%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?